Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Change in Receivables (2023 - 2025)

Historic Change in Receivables for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $49000.0.

  • Artiva Biotherapeutics' Change in Receivables rose 13858.27% to $49000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$509000.0, marking a year-over-year increase of 6560.81%. This contributed to the annual value of -$1.0 million for FY2024, which is 24281.77% down from last year.
  • As of Q3 2025, Artiva Biotherapeutics' Change in Receivables stood at $49000.0, which was up 13858.27% from -$204000.0 recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Change in Receivables registered a high of $88000.0 during Q1 2025, and its lowest value of -$888000.0 during Q4 2023.
  • Its 3-year average for Change in Receivables is -$229888.9, with a median of -$204000.0 in 2025.
  • In the last 5 years, Artiva Biotherapeutics' Change in Receivables crashed by 5875.0% in 2024 and then surged by 14093.02% in 2025.
  • Over the past 3 years, Artiva Biotherapeutics' Change in Receivables (Quarter) stood at -$888000.0 in 2023, then skyrocketed by 50.23% to -$442000.0 in 2024, then surged by 111.09% to $49000.0 in 2025.
  • Its Change in Receivables stands at $49000.0 for Q3 2025, versus -$204000.0 for Q2 2025 and $88000.0 for Q1 2025.